SPECT Scanning Services Segmentation
The global SPECT scanning services market is segmented and analyzed for demand and supply by application into oncology, brain disorders, cardiology, and bone disorders, out of which, the oncology segment is anticipated to hold the highest share over the forecast period on the back of growing count of oncology trials to treat varied kind of cancer, and growth in per capita income. For instance, in 2021, the number of oncology trials grew at record levels, up 56% from 2016, and a record 30 oncology novel active substances (NASs) were first introduced worldwide.
Our in-depth analysis of the global SPECT scanning services market includes the following segments:
|
By Type |
|
|
By Design |
|
|
By Application |
|
|
By End-User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of spect scanning services is evaluated at USD 2.68 billion.
SPECT Scanning Services Market size was over USD 2.5 billion in 2024 and is poised to exceed USD 7.13 billion by 2037, growing at over 8.4% CAGR during the forecast period i.e., between 2025-2037.
North America industry is poised to hold largest revenue share by 2037, impelled by rising prevalence of several heart diseases, increasing neurological disorders, growing healthcare expenditure, and a notable presence of major key players in the region.
The major players in the market are Siemens Healthcare GmbH, Toshiba International Corporation, Mediso Ltd., DIGIRAD CORPORATION, DDD-Diagnostic A/S, Positron Corporation, Cubresa, Inc., Koninklijke Philips N.V., and others.
